Prematurity and programming: Contribution of neonatal Intensive Care Unit interventions

Journal of Developmental Origins of Health and Disease

Volumn 4, Issue 2, 2013, Pages 121-133

  Kalhan, S C ^a,b   Wilson Costello, D ^c  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

insulin resistance; methionine; parenteral nutrition; prematurity; programming

Indexed keywords

EID: 84882933822     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S204017441200061X     Document Type: Review

References (117)

1. Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N Engl J Med. 2008; 358, 1700-1711
2. Fanaroff AA, Hack M, Walsh MC. The NICHD neonatal research network: Changes in practice and outcomes during the first 15 years. Semin Perinatol. 2003; 27, 281-287 (Pubitemid 37099808)
3. Hack M. Adult outcomes of preterm children. J Dev Behav Pediatr. 2009; 30, 460-470
4. Wilson-Costello D, Friedman H, Minich N, Fanaroff AA, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics. 2005; 115, 997-1003
5. Doyle LW, Anderson PJ. Adult outcome of extremely preterm infants. Pediatrics. 2010; 126, 342-351
6. Eriksson J, Forsen T, Tuomilehto J, Osmond C, Barker D. Fetal and childhood growth and hypertension in adult life. Hypertension. 2000; 36, 790-794
7. Hovi P, Andersson S, Raikkonen K, et al. Ambulatory blood pressure in young adults with very low birth weight. J Pediatr. 2010; 156, 54,59.e1
8. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: A systematic review. JAMA. 2008; 300, 2886-2897
9. Warner MJ, Ozanne SE. Mechanisms involved in the developmental programming of adulthood disease. Biochem J. 2010; 427, 333-347
10. Simmons R. Developmental origins of adult metabolic disease: Concepts and controversies. Trends Endocrinol Metab. 2005; 16, 390-394 (Pubitemid 41338745)
11. Ehrenkranz RA, Younes N, Lemons JA, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics. 1999; 104, 280-289 (Pubitemid 29362137)
12. Philippidis H, Ballard FJ. The development of gluconeogenesis in rat liver: Experiments in vivo. Biochem J. 1969; 113, 651-657
13. Filippi L, Messeri A, Dani C, et al. Redox status in very-low birth-weight newborns. Biol Neonate. 2004; 85, 210-216 (Pubitemid 38437704)
14. Avery SV. Molecular targets of oxidative stress. Biochem J. 2011; 434, 201-210
15. Kalhan SC, Marczewski SE. Methionine, homocysteine, one carbon metabolism and fetal growth. Rev Endocr Metab Disord. 2012; 13, 109-119
16. Prudova A, Bauman Z, Braun A, et al. S-Adenosylmethionine stabilizes cystathionine b synthase and modulates redox capacity. Proc Nat Acad Sci. 2006; 103, 6489-6494
17. Vivitsky V, Mosharov E, Tritt M, Ataullakhanov F, Banerjee R. Redox regulation of homocysteine-dependent glutathione synthesis. Redox Rep. 2003; 8, 57-63 (Pubitemid 36204255)
18. Kabil O, Banerjee R. Redox biochemistry of hydrogen sulfide. J Biol Chem. 2010; 285, 21903-21907
19. Kalhan S, Parimi P. Gluconeogenesis in the fetus and neonate. Semin Perinatol. 2000; 24, 94-106 (Pubitemid 30228402)
20. Kalhan SC, Bier DM. Protein and amino acid metabolism in the human newborn. Annu Rev Nutr. 2008; 28, 389-410
21. Srinivasan M, Laychock SG, Hill DJ, Patel MS. Neonatal nutrition: Metabolic programming of pancreatic islets and obesity. Exp Biol Med (Maywood). 2003; 228, 15-23 (Pubitemid 36077623)
22. Symonds ME, Sebert SP, Hyatt MA, Budge H. Nutritional programming of the metabolic syndrome. Nat Rev Endocrinol. 2009; 5, 604-610
23. Hay WW, Thureen P. Protein for preterm infants: How much is needed? How much is enough? How much is too much? Pediatr Neonatol. 2010; 51, 198-207
24. Olsen IE, Richardson DK, Schmid CH, Ausman LM, Dwyer JT. Intersite differences in weight growth velocity of extremely premature infants. Pediatrics. 2002; 110, 1125-1132 (Pubitemid 35425187)
25. Cooke RJ, Ainsworth SB, Fenton AC. Postnatal growth retardation: A universal problem in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2004; 89, F428-F430 (Pubitemid 39178821)
26. Hay WW Jr, Thureen PJ. Early postnatal administration of intravenous amino acids to preterm, extremely low birth weight infants. J Pediatr. 2006; 148, 291-294
27. Poindexter BB, Langer JC, Dusick AM, Ehrenkranz RA, National Institute of Child Health and Human Development Neonatal Research Network. Early provision of parenteral amino acids in extremely low birth weight infants: Relation to growth and neurodevelopmental outcome. J Pediatr. 2006; 148, 300-305
28. te Braake FW, van den Akker CH, Wattimena DJ, Huijmans JG, van Goudoever JB. Amino acid administration to premature infants directly after birth. J Pediatr. 2005; 147, 457-461 (Pubitemid 41446538)
29. Jadhav P, Parimi PS, Kalhan SC. Parenteral amino acid and metabolic acidosis in premature infants. J Parenter Enteral Nutr. 2007; 31, 278-283 (Pubitemid 47025689)
30. Ibrahim HM, Jeroudi MA, Baier RJ, Dhanireddy R, Krouskop RW. Aggressive early total parental nutrition in low-birthweight infants. J Perinatol. 2004; 24, 482-486 (Pubitemid 39149365)
31. Augustyniak RA, Singh K, Zeldes D, Singh M, Rossi NF. Maternal protein restriction leads to hyperresponsiveness to stress and salt-sensitive hypertension in male offspring. Am J Physiol Regul Integr Comp Physiol. 2010; 298, R1375-R1382
32. Kalhan SC, Uppal SO, Moorman JL, et al. Metabolic and genomic response to dietary isocaloric protein restriction in the rat. J Biol Chem. 2011; 286, 5266-5277
33. Ingenbleek Y, Hardillier E, Jung L. Subclinical protein malnutrition is a determinant of hyperhomocysteinemia. Nutrition. 2002; 18, 40-46 (Pubitemid 34097711)
34. Embleton NE, Pang N, Cooke RJ. Postnatal malnutrition and growth retardation: An inevitable consequence of current recommendations in preterm infants? Pediatrics. 2001; 107, 270-273 (Pubitemid 32121240)
35. Stephens BE, Walden RV, Gargus RA, et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics. 2009; 123, 1337-1343
36. Heird WC, Hay W, Helms RA, et al. Pediatric parenteral amino acid mixture in low birth weight infants. Pediatrics. 1988; 81, 41-50 (Pubitemid 18044290)
37. Blanco CL, Gong AK, Green BK, et al. Early changes in plasma amino acid concentrations during aggressive nutrition therapy in extremely low birth weight infants. J Pediatr. 2011; 158, 543-548
38. Battista MA, Price PT, Kalhan SC. Effect of parenteral amino acids on leucine and urea kinetics in preterm infants. J Pediatr. 1996; 128, 130-140
39. Thomas B, Gruca LL, Bennett C, et al. Metabolism of methionine in the newborn infant: Response to the parenteral and enteral administration of nutrients. Pediatr Res. 2008; 64, 381-386. PMCID: 2651408
40. Hollingsworth JW, Maruoka S, Boon K, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. Journal of Clin Invest. 2008; 118, 3462-3469
41. Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child. 2009; 94, 180-184
42. Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Effect of supplemental folic acid in pregnancy on childhood asthma: A prospective birth cohort study. Am J Epidemiol. 2009; 170, 1486-1493
43. Wilson DC, Cairns P, Halliday HL, et al. Randomised controlled trial of an aggressive nutritional regimen in sick very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 1997; 77, F4-F11 (Pubitemid 28201620)
44. Dinerstein A, Nieto RM, Solana CL, et al. Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants. J Perinatol. 2006; 26, 436-442 (Pubitemid 43970954)
45. Cooke RJ, Griffin I. Altered body composition in preterm infants at hospital discharge. Acta Paediatr. 2009; 98, 1269-1273
46. Yajnik CS, Fall CH, Coyaji KJ, et al. Neonatal anthropometry: The thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes Relat Metab Disord. 2003; 27, 173-180 (Pubitemid 36255798)
47. Ehrenkranz RA, Dusick AM, Vohr BR, et al. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics. 2006; 117, 1253-1261 (Pubitemid 46071519)
48. Peeples JM, Carlson SE, Werkman SH, Cooke RJ. Vitamin A status of preterm infants during infancy. Am J Clin Nutr. 1991; 53, 1455-1459 (Pubitemid 21898898)
49. Greene HL, Phillips BL, Franck L, et al. Persistently low blood retinol levels during and after parenteral feeding of very low birth weight infants: Examination of losses into intravenous administration sets and a method of prevention by addition to a lipid emulsion. Pediatrics. 1987; 79, 894-900 (Pubitemid 17079002)
50. Shenai JP, Chytil F, Stahlman MT. Liver vitamin A reserves of very low birth weight neonates. Pediatr Res. 1985; 19, 892-893 (Pubitemid 15226852)
51. Shenai JP, Chytil F, Stahlman MT. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res. 1958; 19, 185-188
52. Spears K, Cheney C, Zerzan J. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very low birth weight infants. Am J Clin Nutr. 2004; 80, 1589-1594 (Pubitemid 41103858)
53. Shenai JP, Kennedy KA, Chytil F, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr. 1987; 111, 269-277 (Pubitemid 17127140)
54. Pearson E, Bose C, Snidow T, et al. Trial of vitamin A supplementation in very low birth weight infants at risk for bronchopulmonary dysplasia. J Pediatr. 1992; 121, 420-427
55. Wardle SP, Hughes A, Chen S, Shaw NJ. Randomised controlled trial of oral vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch Dis Child Fetal Neonatal Ed. 2001; 84, F9-F13 (Pubitemid 32060163)
56. Tyson JE, Wright LL, Oh W, et al. Vitamin A supplementation for extremely low birth weight infants. N Engl J Med. 1999; 340, 1962-1968 (Pubitemid 29288272)
57. Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short and long term morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2011; 10, Art. No.: CD000501. doi:10.1002/14651858.CD000501. pub3
58. Barros FC, Bhutta ZA, Batra M, et al. Global report on preterm birth and stillbirth (3 of 7): Evidence for effectiveness of interventions. BMC Pregnancy Childbirth. 2010; 10(Suppl. 1), S3
59. Ambalavanan N, Tyson JE, Kennedy KA, et al. Vitamin A supplementation for extremely low birth weight infants: Outcome at 18 to 22 months. Pediatrics. 2005; 115, e249-e254 (Pubitemid 43373006)
60. Rowling MJ, McMullen MH, Schalinske KL. Vitamin A and its derivatives induce hepatic glycine N-methyltransferase and hypomethylation of DNA in rats. J Nutr. 2002; 132, 365-369 (Pubitemid 34208734)
61. Rowling MJ, Schalinske KL. Retinoid compounds activate and induce hepatic glycine N-methyltransferase in rats. J Nutr. 2001; 131, 1914-1917 (Pubitemid 32661058)
62. McMullen MH, Rowling MJ, Ozias MK, Schalinske KL. Activation and induction of glycine N-methyltransferase by retinoids are tissue and gender specific. Arch Biochem Biophys. 2002; 401, 73-80 (Pubitemid 34852247)
63. Rowling MJ, Schalinske KL. Retinoic acid and glucocorticoid treatment induce hepatic glycine N-methyltransferase and lower plasma homocysteine concentrations in rats and rat hepatoma cells. J Nutr. 2003; 133, 3392-3398 (Pubitemid 37409464)
64. Kihara T, Matsuo T, Sakamoto M, Yasuda Y, Tanimura T. Effects of the neonatal vitamin A exposure on behaviors of adult rats. J Toxicol Sci. 1995; 20, 93-101
65. Csaba G, Kovacs P, Pallinger E. Transgenerational effect of neonatal vitamin A or D treatment (hormonal imprinting) on the hormone content of rat immune cells. Horm Metab Res. 2007; 39, 197-201 (Pubitemid 46580618)
66. Coluccia A, Borracci P, Belfiore D, Renna G, Carratu MR. Late embryonic exposure to all trans retinoic acid induces a pattern of motor deficits unrelated to the developmental stage. Neurotoxicology. 2009; 30, 1120-1126
67. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav. 2011; 59, 279-289
68. Drake AJ, Tang JI, Nyirenda MJ. Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. Clin Sci (Lond). 2007; 113, 219-232 (Pubitemid 47372680)
69. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci (Lond). 2000; 98, 137-142 (Pubitemid 30105520)
70. Dessens AB, Haas HS, Koppe JG. Twenty-year follow up of antenatal corticosteroid treatment. Pediatrics. 2000; 105, E77
71. Finken MJ, Keijzer-Veen MG, Dekker FW, et al. Antenatal glucocorticoid treatment is not associated with long term metabolic risks in individuals born before 32 weeks of gestation. Arch Dis Child Fetal Neonatal Ed. 2008; 93, F442-F447
72. Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30 year follow up of a randomised controlled trial. Lancet. 2005; 365, 1856-1862 (Pubitemid 40744963)
73. Dalziel SR, Rea HH, Walker NK, et al. Long term effects of antenatal betamethasone on lung function: 30 year follow up of a randomised controlled trial. Thorax. 2006; 61, 678-683 (Pubitemid 44211774)
74. Dalziel SR, Lim VK, Lambert A, et al. Antenatal exposure to betamethasone: Psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ. 2005; 331, 665
75. Wapner RJ, Sorokin Y, Mele L, et al. Long term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007; 357, 1190-1198 (Pubitemid 47443178)
76. Peltoniemi OM, Kari MA, Lano A, et al. Two year follow up of a randomised trial with repeated antenatal betamethasone. Arch Dis Child Fetal Neonatal Ed. 2009; 94, F402-F406
77. Yates H, Newell S. Postnatal intravenous steroids and long term neurological outcome: Recommendations from meta analyses. Arch Dis Child Fetal Neonatal Ed. 2011; 97, F299-F303
78. Wilson-Costello D, Walsh MC, Langer JC, et al. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: Effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics. 2009; 123, e430-e437
79. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely low birth weight infants. N Engl J Med. 2001; 344, 95-101 (Pubitemid 32052498)
80. le Cras TD, Markhan NE, Morris KG, et al. Neonatal dexamethasone treatment increases the risk for pulmonary hypertension in adult rats. Am J Physiol Lung Cell Mol Physiol. 2000; 278, L822-L829 (Pubitemid 30220044)
81. Flier NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2006, CD000399
82. Subhedar N, Dewhurst C. Is nitric oxide effective in preterm infants? Arch Dis Child Fetal and Neonatal Ed. 2007; 92, 337-341
83. Donohue PK Gilmore MM, Cristofalo E, et al. Inhaled nitric oxide in preterm infants: A systematic review. Pediatrics. 2011; 127, e414-e422
84. Cole FS, Alleyene C, Barks JD, et al. NIH consensus development conference statement: Inhaled nitric oxide therapy for premature infants. Pediatrics. 2011; 127, 363-369
85. Weinberger B, Laskin DL, Heck DE, Laskin JD. The toxicology of inhaled nitric oxide. Toxicol Sci. 2001; 59, 5-16 (Pubitemid 32117977)
86. Illi B, Colussi C, Grasselli A, et al. NO sparks off chromatin: Tales of a multifaceted epigenetic regulator. Pharmacol Ther. 2009; 123, 344-352
87. Nott A, Riccio A. Nitric oxide-mediated epigenetic mechanisms in developing neurons. Cell Cycle. 2009; 8, 725-730
88. Keanney JF Jr, Simon DI, Stamler JS, et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest. 1993; 91, 1582-1589 (Pubitemid 23127360)
89. Lin YS, Nguyen C, Mendoza JL, et al. Preclinical pharmacokinetics, interspecies scaling and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J Pharmacol Exp Ther. 1999; 288, 371-378 (Pubitemid 29113511)
90. Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev. 2004; 25, 581-611 (Pubitemid 39099316)
91. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 31 retinopathy of prematurity. N Engl J Med. 2011; 364, 603-615
92. Wang Y, Fei D, Venderlaan M, Song A. Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro. Angiogenesis. 2004; 7, 335-345 (Pubitemid 40767935)
93. Gerber HP, Hillan KJ, Ryan AM, et al. VEGF is required for growth and survival in neonatal mice. Development. 1999; 126, 1149-1159 (Pubitemid 29182112)
94. Gerber HP, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med. 1999; 5, 623-628 (Pubitemid 29289424)
95. Wu WC, Lai CC, Chen KJ, et al. Long-term tolerability and serum concentration of bevacizumab (avastin) when injected in newborn rabbit eyes. Invest Ophthalmol Vis Sci. 2010; 51, 3701-3708
96. Maffini MV, Rubin BS, Sonnenschein C, Sotoi AM. Endocrine disruptors and reproductive health: The case of bisphenol-A. Mol Cell Endocr. 2006; 254-255, 179-186 (Pubitemid 44041761)
97. Calafat AM, Weuve J, Ye X, et al. Exposure to bisphenol A and other phenols in Neonatal Intensive Care Unit premature infants. Environ Health Perspect. 2009; 117, 639-644
98. Dolibnoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Nat Acad Sci. 2007; 104, 13056-13061 (Pubitemid 351737592)
99. Jasarevic E, Sieli PT, Twellman EE, et al. Disruption of adult expression of sexually selected traits by developmental exposure to bisphenol A. Proc Nat Acad Sci. 2011; 108, 11715-11720
100. Hack M, Merkatz IR, McGrath SK, Jones PK, Fanaroff AA. Catch-up growth in very low birth weight infants. Am J Dis Child. 1984; 138, 370-375 (Pubitemid 14160565)
101. Brandt I, Sticker EJ, Gausche R, Lentze MJ. Catch-up growth of supine length/height of very low birth weight, small for gestational age preterm infants to adulthood. J Pediatr. 2005; 147, 662-668 (Pubitemid 41598341)
102. Itabashi K, Mishina J, Tada H, et al. Longitudinal follow up of height up to five years of age in infants born preterm small for gestational age; comparison to full term small for gestational age infants. Early Hum Dev. 2007; 83, 327-333 (Pubitemid 46561169)
103. Uthaya S, Thomas EL, Hamilton G, et al. Altered adiposity after extremely preterm birth. Pediatr Res. 2005; 57, 211-215 (Pubitemid 40165597)
104. Cooke RJ, Griffin IJ, McCormick K. Adiposity is not altered in preterm infants fed with a nutrient enriched formula after hospital discharge. Pediatr Res. 2010; 67, 660-664
105. Yeung MY. Postnatal growth, neurodevelopment and altered adiposity after preterm birth-from a clinical nutrition perspective. Acta Paediatr. 2006; 95, 909-917
106. Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: Systematic reviews and hopeful suggestions. Acta Paediatr. 2006; 95, 904-908
107. Monteiro PO, Victora CG. Rapid growth in infancy and childhood and obesity in later life-A systematic review. Obes Rev. 2005; 6, 143-154 (Pubitemid 40604423)
108. Wehkalampi K, Hovi P, Dunkel L, et al. Advanced pubertal growth spurt in subjects born preterm: The Helsinki study of very low birth weight adults. J Clin Endocrinol Metab. 2011; 96, 525-533
109. Bazaes RA, Alegría A, Pittaluga E, et al. Determinants of insulin sensitivity and secretion in very low birth weight children. J Clin Endocrinol Metab. 2004; 89, 1267-1272 (Pubitemid 38368424)
110. Stettler N, Iotova V. Early growth patterns and long term obesity risk. Curr Opin Clin Nutr Metab Care. 2010; 13, 294-299
111. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med. 2004; 351, 2179-2186. Erratum in: N Engl J Med. 2004; 351, 2888 (Pubitemid 39507630)
112. Fewtrell MS, Doherty C, Cole TJ, et al. Effects of size at birth, gestational age and early growth in preterm infants on glucose and insulin concentrations at 9-12 years. Diabetologia. 2000; 43, 714-717 (Pubitemid 30409146)
113. Hovi P, Andersson S, Eriksson JG, et al. Glucose regulation in young adults with very low birth weight. N Engl J Med. 2007; 356, 2053-2063. PubMed PMID: 17507704 (Pubitemid 46789895)
114. Finken MJ, Keijzer-Veen MG, Dekker FW, et al, Dutch POPS-19 Collaborative Study Group. Preterm birth and later insulin resistance: Effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia. 2006; 49, 478-485 (Pubitemid 43277870)
115. Rotteveel J, van Weissenbruch MM, Twisk JW, Delemarre-Van de Waal HA. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics. 2008; 122, 313-321
116. Pilgaard K, Færch K, Carstensen B, et al. Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-Aged Danes. Diabetologia. 2010; 53, 2526-2530
117. Kaijser M, Bonamy AK, Akre O, et al. Perinatal risk factors for diabetes in later life. Diabetes. 2009; 58, 523-526